Sponsor

Torl Biotherapeutics LLC

United States 6100 Bristol Parkway, 90230-6604, United States

About the sponsor

Torl Biotherapeutics LLC focuses on clinical research in ovarian cancer, fallopian tube cancer, and peritoneal cancer, with an emphasis on advanced disease in women.

Advanced ovarian cancer
Fallopian tube malignancies
Primary peritoneal cancer

The sponsor’s research activity is centered on gynecologic malignancies that share overlapping clinical features and treatment needs.

About Specializations

Torl Biotherapeutics LLC runs clinical trials in conditions such as Fallopian tube cancer, Ovarian cancer, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Fallopian tube cancer+1

Not yet recruiting

Registered drugNo placebo

Study of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Glatiramer Acetate
Sponsor:Torl Biotherapeutics LLC

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →